JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Revenue PerformanceStable
Percentile Rank86
3Y CAGR+5.7%
5Y CAGR+3.9%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+5.7%/yr
vs -5.0%/yr prior
5Y CAGR
+3.9%/yr
Consistent
Acceleration
+10.7pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
5 yr
Consecutive growthStable
PeriodValueYoY Change
2025$72.34B+7.9%
2024$67.03B+6.7%
2023$62.82B+2.5%
2022$61.30B+0.5%
2021$60.99B+2.1%
2020$59.76B-34.4%
2019$91.11B+21.2%
2018$75.18B+28.3%
2017$58.61B+2.0%
2016$57.49B-